Proteomic analysis of coronary sinus serum reveals leucine-rich α2-glycoprotein as a novel biomarker of ventricular dysfunction and heart failure

Circulation: Heart Failure

Volumn 4, Issue 2, 2011, Pages 188-197

  Watson, Chris J ^a   Ledwidge, Mark T ^a   Phelan, Dermot ^a   Collier, Patrick ^a   Byrne, Jennifer C ^a   Dunn, Michael J ^a   McDonald, Kenneth M ^a   Baugh, John A ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

2 glycoprotein; Heart failure; Hypertension; Leucine rich; Natriuretic peptides

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ALPHA2 GLYCOPROTEIN; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; INTERLEUKIN 6; LEUCINE RICH ALPHA2 GLYCOPROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ACTIN; GLYCOPROTEIN; IL6 PROTEIN, HUMAN; LRG1 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; AGED; ARTICLE; CORONARY SINUS; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIASTOLIC DYSFUNCTION; DIASTOLIC HEART FAILURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ASSAY; SYSTOLIC HEART FAILURE; TISSUE DISTRIBUTION; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; ASYMPTOMATIC DISEASE; BLOOD; CHEMISTRY; CHI SQUARE DISTRIBUTION; DOPPLER ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; IRELAND; METHODOLOGY; MIDDLE AGED; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ACTINS; AGED; ASYMPTOMATIC DISEASES; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CORONARY SINUS; ECHOCARDIOGRAPHY, DOPPLER; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HEART FAILURE; HUMANS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; IRELAND; LOGISTIC MODELS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PROTEIN-SERINE-THREONINE KINASES; PROTEOMICS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RISK ASSESSMENT; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79955930453     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.110.952200     Document Type: Article

References (29)

1. Karuppiah S, Graham F, Ledwidge M, Conlon C, Cahill J, O'Loughlin C, McManus J, McDonald K. Elevated BNP with normal systolic function in asymptomatic individuals at-risk for heart failure: A marker of diastolic dysfunction and clinical risk. Ir J Med Sci. 2006;175:5-13. (Pubitemid 46218031)
2. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, Ohnishi M, Sugimoto Y, Kinoshita M. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 1997;96:509-516. (Pubitemid 27329427)
3. Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, Gardetto N, Wanner E, Maisel AS. Utility of B-natriuretic peptide in detecting diastolic dysfunction: Comparison with Doppler velocity recordings. Circulation. 2002;105:595-601. (Pubitemid 34123434)
4. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-167. (Pubitemid 34764819)
5. Nakatsu T, Shinohata R, Mashima K, Yuki Y, Nishitani A, Toyonaga S, Ogawa H, Hirohata S, Usui S, Kusachi S. Use of plasma B-type natriuretic peptide level to identify asymptomatic hypertensive patients with abnormal diurnal blood pressure variation profiles: Nondippers, extreme dippers, and risers. Hypertens Res. 2007;30:651-658. (Pubitemid 47278324)
6. Albertini JP, Cohen R, Valensi P, Sachs RN, Charniot JC. B-type natriuretic peptide, a marker of asymptomatic left ventricular dysfunction in type 2 diabetic patients. Diabetes Metab. 2008;34:355-362.
7. Martos R, Baugh J, Ledwidge M, O'Loughlin C, Murphy NF, Conlon C, Patle A, Donnelly SC, McDonald K. Diagnosis of heart failure with preserved ejection fraction: Improved accuracy with the use of markers of collagen turnover. Eur J Heart Fail. 2009;11:191-197.
8. Kim HJ, Kang HJ, Lee H, Lee ST, Yu MH, Kim H, Lee C. Identification of S100A8 and S100A9 as serological markers for colorectal cancer. J Proteome Res. 2009;8:1368-1379.
9. Byrne JC, Downes MR, O'Donoghue N, O'Keane C, O'Neill A, Fan Y, Fitzpatrick JM, Dunn M, Watson RW. 2D-DIGE as a strategy to identify serum markers for the progression of prostate cancer. J Proteome Res. 2009;8:942-957.
10. Marouga R, David S, Hawkins E. The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem. 2005;382:669-678. (Pubitemid 40890994)
11. Haupt H, Baudner S. [Isolation and characterization of an unknown, leucine-rich 3.1-S-alpha2-glycoprotein from human serum (author's translation)]. Hoppe Seylers Z Physiol Chem. 1977;358:639-646. (Pubitemid 8274041)
12. Takahashi N, Takahashi Y, Putnam FW. Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum. Proc Natl Acad Sci U S A. 1985;82:1906-1910. (Pubitemid 15060810)
13. Shirai R, Hirano F, Ohkura N, Ikeda K, Inoue S. Up-regulation of the expression of leucine-rich alpha(2)-glycoprotein in hepatocytes by the mediators of acute-phase response. Biochem Biophys Res Commun. 2009; 382:776-779.
14. O'Donnell LC, Druhan LJ, Avalos BR. Molecular characterization and expression analysis of leucine-rich alpha2-glycoprotein, a novel marker of granulocytic differentiation. J Leukoc Biol. 2002;72:478-485.
15. Ai J, Druhan LJ, Hunter MG, Loveland MJ, Avalos BR. LRG-accelerated differentiation defines unique G-CSFR signaling pathways downstream of PU. 1 and C/EBPepsilon that modulate neutrophil activation. J Leukoc Biol. 2008;83:1277-1285. (Pubitemid 351960360)
16. Norkina O, Kaur S, Ziemer D, De Lisle RC. Inflammation of the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol. 2004;286:G1032-G1041. (Pubitemid 38715667)
17. Codina R, Vanasse A, Kelekar A, Vezys V, Jemmerson R. Cytochrome c-induced lymphocyte death from the outside in: Inhibition by serum leucine-rich alpha-2-glycoprotein-1. Apoptosis. 2010;15:139-152.
18. Sun D, Kar S, Carr BI. Differentially expressed genes in TGF-beta 1 sensitive and resistant human hepatoma cells. Cancer Lett. 1995;89: 73-79.
19. Li X, Miyajima M, Jiang C, Arai H. Expression of TGF-betas and TGF-beta type II receptor in cerebrospinal fluid of patients with idiopathic normal pressure hydrocephalus. Neurosci Lett. 2007;413:141-144. (Pubitemid 46195188)
20. Lopez B, Gonzalez A, Varo N, Laviades C, Querejeta R, Diez J. Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension. 2001;38:1222-1226. (Pubitemid 34252835)
21. Martos R, Baugh J, Ledwidge M, O'Loughlin C, Conlon C, Patle A, Donnelly SC, McDonald K. Diastolic heart failure: Evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation. 2007;115:888-895. (Pubitemid 46294729)
22. Querejeta R, Lopez B, Gonzalez A, Sanchez E, Larman M, Martinez Ubago JL, Diez J. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: Relation to myocardial fibrosis. Circulation. 2004;110:1263-1268. (Pubitemid 39202343)
23. Watson JA, Watson CJ, McCrohan AM, Woodfine K, Tosetto M, McDaid J, Gallagher E, Betts D, Baugh J, O'Sullivan J, Murrell A, Watson RW, McCann A. Generation of an epigenetic signature by chronic hypoxia in prostate cells. Hum Mol Genet. 2009;18:3596-3604.
24. Patwa TH, Zhao J, Anderson MA, Simeone DM, Lubman DM. Screening of glycosylation patterns in serum using natural glycoprotein microarrays and multi-lectin fluorescence detection. Anal Chem. 2006;78:6411-6421. (Pubitemid 44413592)
25. Kentsis A, Lin YY, Kurek K, Calicchio M, Wang YY, Monigatti F, Campagne F, Lee R, Horwitz B, Steen H, Bachur R. Discovery and validation of urine markers of acute pediatric appendicitis using highaccuracy mass spectrometry. Ann Emerg Med. 2009;1:62-70.
26. Gauldie J, Bonniaud P, Sime P, Ask K, Kolb M. TGF-beta, Smad3 and the process of progressive fibrosis. Biochem Soc Trans. 2007;35: 661-664. (Pubitemid 47310335)
27. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Vahanian A, Camm J, De Caterina R, Dean V, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Auricchio A, Bax J, Bohm M, Corra U, della Bella P, Elliott PM, Follath F, Gheorghiade M, Hasin Y, Hernborg A, Jaarsma T, Komajda M, Kornowski R, Piepoli M, Prendergast B, Tavazzi L, Vachiery JL, Verheugt FW, Zannad F. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008;10:933-989.
28. O'Hanlon R, O'Shea P, Ledwidge M, O'Loughlin C, Lange S, Conlon C, Phelan D, Cunningham S, McDonald K. The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients. J Card Fail. 2007;13:50-55. (Pubitemid 46330833)
29. Serada S, Fujimoto M, Ogata A, Terabe F, Hirano T, Iijima H, Shinzaki S, Nishikawa T, Ohkawara T, Iwahori K, Ohguro N, Kishimoto T, Naka T. iTRAQ-based proteomic identification of leucine-rich alpha-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases. Ann Rheum Dis. 2010;69:770-774.